Informations générales (source: ClinicalTrials.gov)
A Registry to Collect Characteristics and Outcomes From Patients With Solid Tumors Profiled With a Next-Generation Sequencing Test (WAYFIND-R)
Observational [Patient Registry]
Hoffmann-La Roche (Voir sur ClinicalTrials)
août 2020
décembre 2026
10 octobre 2024
WAYFIND-R is a registry that aims to capture high-quality real-world data linking
next-generation sequencing, treatments and outcomes from cancer patients diagnosed with a
solid tumour. The WAYFIND-R has three main overarching objectives: 1. To provide a
platform to support the design and conduct of clinical and epidemiological research; 2.
To develop an evidence-generation platform to better understand health outcomes and
cancer care processes; and 3. To characterize the treatments and clinical course of solid
tumor cancers in patients who have undergone NGS testing.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT CURIE | 04/09/2024 13:49:54 | Contact (sur clinicalTrials) | |||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CLCC INSTITUT GUSTAVE ROUSSY | Contact (sur clinicalTrials) | ||||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Aphm; Cpcet - 13385 - Marseille - France | Contact (sur clinicalTrials) | ||||
| Centre Eugene Marquis - 35000 - Rennes - France | Contact (sur clinicalTrials) | ||||
| Centre Francois Baclesse; Recherche Clinique - 14076 - Caen - France | Contact (sur clinicalTrials) | ||||
| Centre hospitalier universitaire Dijon-Bourgogne - 21079 - Dijon - France | Contact (sur clinicalTrials) | ||||
| Centre Jean Perrin; Division De Recherche Clinique - 63011 - Clermont Ferrand - France | Contact (sur clinicalTrials) | ||||
| Centre Leon Berard; Oncologie Genetique - 69373 - Lyon - France | Contact (sur clinicalTrials) | ||||
| Centre Oscar Lambret - 59020 - Lille - France | Contact (sur clinicalTrials) | ||||
| CH de Cornouailles - 29107 - Quimper - France | Contact (sur clinicalTrials) | ||||
| CHI de Toulon - Hôpital Sainte Musse - 83056 - Toulon - France | Contact (sur clinicalTrials) | ||||
| Chu Brest - Hôpital Morvan - 29200 - Brest - France | Contact (sur clinicalTrials) | ||||
| CHU Saint Etienne - Hôpital Nord - 42055 - Saint Etienne - France | Contact (sur clinicalTrials) | ||||
| Hôpital Franco-Britannique- Fondation Cognacq-Jay; Cancerologie - 92300 - Levallois-Perret - France | Contact (sur clinicalTrials) | ||||
| HOPITAL JEAN MINJOZ; Oncologie - 25030 - Besancon - France | Contact (sur clinicalTrials) | ||||
| Hôpital Privé de la Loire, Ramsay Saint Etienne - 42100 - St Etienne - France | Contact (sur clinicalTrials) | ||||
Critères
Tous
Inclusion Criteria:
- Participant is an adult (according to the age of majority as defined by local
regulations)
- Participant is currently diagnosed with any type of solid tumour cancer, at any
stage of the disease, at the enrollment date (informed consent date)
- Participant has undergone NGS testing, no longer than 3 months prior to the
enrollment date, irrespective of the availability of test results
- Informed consent has been obtained from the participant or legally authorized
representative, as per local regulations
- Participant is an adult (according to the age of majority as defined by local
regulations)
- Participant is currently diagnosed with any type of solid tumour cancer, at any
stage of the disease, at the enrollment date (informed consent date)
- Participant has undergone NGS testing, no longer than 3 months prior to the
enrollment date, irrespective of the availability of test results
- Informed consent has been obtained from the participant or legally authorized
representative, as per local regulations
-Participant has a prior or current diagnosis of haematological malignancy